ArticleOncology letters2024

Ramucirumab in second‑line advanced colorectal cancer therapy: A study on therapeutic outcomes and hepatic sinusoidal platelet aggregation.

Keisuke Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.